Literature DB >> 33019978

Histone methylation status of H3K4me3 and H3K9me3 under methionine restriction is unstable in methionine-addicted cancer cells, but stable in normal cells.

Jun Yamamoto1, Qinghong Han2, Sachiko Inubushi3, Norihiko Sugisawa3, Kazuyuki Hamada3, Hiroto Nishino3, Kentaro Miyake4, Takafumi Kumamoto4, Ryusei Matsuyama4, Michael Bouvet5, Itaru Endo6, Robert M Hoffman7.   

Abstract

Methionine addiction is a fundamental and general hallmark of cancer. Methionine addiction prevents cancer cells, but not normal cells from proliferation under methionine restriction (MR). Previous studies reported that MR altered the histone methylation levels in methionine-addicted cancer cells. However, no study has yet compared the status of histone methylation status, under MR, between cancer cells and normal cells. In the present study, we compared the histone methylation status between cancer cells and normal fibroblasts of H3K4me3 and H3K9me3, using recombinant methioninase (rMETase) to effect MR. Human lung and colon cancer cell lines and human normal foreskin fibroblasts were cultured in control medium or medium with rMETase. The viability of foreskin fibroblasts was approximately 10 times more resistant to rMETase than the cancer cells in vitro. Proliferation only of the cancer cells ceased under MR. The histone methylation status of H3K4me3 and H3K9me3 under MR was evaluated by immunoblotting. The levels of the H3K4me3 and H3K9me3 were strongly decreased by MR in the cancer cells. In contrast, the levels of H3K4me3 and H3K9me3 were not altered by MR in normal fibroblasts. The present results suggest that histone methylation status of H3K4me3 and H3K9me3 under MR was unstable in cancer cells but stable in normal cells and the instability of histone methylation status under MR may determine the high methionine dependency of cancer cells to survive and proliferate.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Histone methylation; Methioninase; Methionine addiction; Methionine dependence; Methionine restriction

Year:  2020        PMID: 33019978     DOI: 10.1016/j.bbrc.2020.09.108

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Deletion of MTAP Highly Sensitizes Osteosarcoma Cells to Methionine Restriction With Recombinant Methioninase.

Authors:  Yusuke Aoki; Yasunori Tome; Qinghong Han; Jun Yamamoto; Kazuyuki Hamada; Noriyuki Masaki; Yutaro Kubota; Michael Bouvet; Kotaro Nishida; Robert M Hoffman
Journal:  Cancer Genomics Proteomics       Date:  2022 May-Jun       Impact factor: 4.069

2.  Efficacy of Oral Recombinant Methioninase and Eribulin on a PDOX Model of Triple-negative Breast Cancer (TNBC) Liver Metastasis.

Authors:  Hye In Lim; Y U Sun; Qinghong Han; Jun Yamamoto; Robert M Hoffman
Journal:  In Vivo       Date:  2021 Sep-Oct       Impact factor: 2.155

3.  Extent and Instability of Trimethylation of Histone H3 Lysine Increases With Degree of Malignancy and Methionine Addiction.

Authors:  Jun Yamamoto; Yusuke Aoki; Sachiko Inubushi; Qinghong Han; Kazuyuki Hamada; Yoshihiko Tashiro; Kentaro Miyake; Ryusei Matsuyama; Michael Bouvet; Steven G Clarke; Itaru Endo; Robert M Hoffman
Journal:  Cancer Genomics Proteomics       Date:  2022 Jan-Feb       Impact factor: 4.069

4.  Over-methylation of Histone H3 Lysines Is a Common Molecular Change Among the Three Major Types of Soft-tissue Sarcoma in Patient-derived Xenograft (PDX) Mouse Models.

Authors:  Yusuke Aoki; Jun Yamamoto; Yasunori Tome; Kazuyuki Hamada; Noriyuki Masaki; Sachiko Inubushi; Yoshihiko Tashiro; Michael Bouvet; Itaru Endo; Kotaro Nishida; Robert M Hoffman
Journal:  Cancer Genomics Proteomics       Date:  2021 Nov-Dec       Impact factor: 4.069

5.  Linkage of methionine addiction, histone lysine hypermethylation, and malignancy.

Authors:  Jun Yamamoto; Sachiko Inubushi; Qinghong Han; Yoshihiko Tashiro; Norihiko Sugisawa; Kazuyuki Hamada; Yusuke Aoki; Kentaro Miyake; Ryusei Matsuyama; Michael Bouvet; Steven G Clarke; Itaru Endo; Robert M Hoffman
Journal:  iScience       Date:  2022-03-25

6.  A Key Silencing Histone Mark on Chromatin Is Lost When Colorectal Adenocarcinoma Cells Are Depleted of Methionine by Methionine γ-Lyase.

Authors:  Samanta Raboni; Serena Montalbano; Stephanie Stransky; Benjamin A Garcia; Annamaria Buschini; Stefano Bettati; Simone Sidoli; Andrea Mozzarelli
Journal:  Front Mol Biosci       Date:  2021-10-01

7.  4,5-Dimethoxycanthin-6-one is a novel LSD1 inhibitor that inhibits proliferation of glioblastoma cells and induces apoptosis and pyroptosis.

Authors:  Wei Li; Bai-Sheng Huang; Yuan-Yuan Xiong; Li-Jian Yang; Li-Xiang Wu
Journal:  Cancer Cell Int       Date:  2022-01-18       Impact factor: 5.722

Review 8.  Amino acid metabolism as a therapeutic target in cancer: a review.

Authors:  Molly Endicott; Michael Jones; Jonathon Hull
Journal:  Amino Acids       Date:  2021-07-22       Impact factor: 3.520

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.